Silicon Canals
TRENDING
  • Mobility
  • AI
  • FinTech
  • Software & SaaS
No Result
View All Result
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdampartner
  • Events
  • Newsletter
  • Jobs
  • About
    • Partner with Silicon Canals
    • Team
    • Contact
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdampartner
  • Events
  • Newsletter
  • Jobs
  • About
    • Partner with Silicon Canals
    • Team
    • Contact
No Result
View All Result
Silicon Canals
No Result
View All Result

One of the hottest Amsterdam based AI-startup raises €10.13M in Series A to support COVID-19 research

Shubham Sharma by Shubham Sharma
August 20, 2020
in News, (Crowd)funding, Amsterdam, Health & Medtech, Promoted content, Startups
0
One of the hottest Amsterdam based AI-startup raises €10.13M in Series A to support COVID-19 research
145
SHARES
LinkedInTwitterWhatsAppFacebook

Artificial Intelligence or AI is a wonderful tool that is being used in various sectors to accelerate development. Healthcare and medtech have also benefited from AI, be it discovering new drugs or helping healthcare professionals exchange information. Amsterdam-based Castor is one such startup that’s using AI to offer a cloud-based clinical data platform that simplifies the clinical trial process. The startup has now raised €10.13M in Series A to support COVID-19 research. 

Furthering COVID-19 research support

Castor offers an Electronic Data Capture (EDC) system for medical researchers to help them easily capture and integrate high-quality data from any source on one compliant platform. It helps set up data capture forms, collaborate with colleagues, invite patients through questionnaires, import, export and analyse their data in a secure, compliant cloud environment, all without elaborate training or technical skills. 

 - Partner content -
Cost of software - The Software house
The cost of building software
Marek Gajda, CTO of The Software House, shares his insights on building high-quality...Show More
Marek Gajda, CTO of The Software House, shares his insights on building high-quality software. Show Less
Read more

Back in February this year, Castor made its platform freely available for all non-profit COVID-19 research. This latest funding will help the company further extend their support for the research as they are the sole providers capable of enabling large-scale decentralised trials to accelerate the research. As per Castor, over 200 COVID-19 projects across 33 countries are currently running on their platform, including the World Health Organization’s global Solidarity trial. 

Using Castor EDC, over 10,000,000 COVID-19 data points have been captured, the company says. Additionally, 50 COVID-19 projects will be making their data reusable and accessible to others, in order to improve collaboration for developing a vaccine for the coronavirus.

Funding to help Castor strengthen its support

Founded back in 2012 by Derk Arts, prior to the latest funding round, Castor EDS had secured a total funding of €6.4 million. In its latest Series A funding round, Castor raised a notable  €10.13 million. The round was led by Two Sigma Ventures while Hambrecht Ducera Growth Ventures and existing investor INKEF Capital participated as well. The new funding will be utilised by the startup to strengthen its support for patient-centric, remote trials. It will also enable the company’s customers to maximise value from existing and newly generated data throughout the clinical trial process. 

“There are three key challenges that need to be addressed in the clinical trial space: making research more patient-centric, maximizing the impact of data on human lives, and better addressing the needs of underserved communities,” says Derk Arts, MD, PhD, CEO & Founder of Castor. “With this new investment, we will be able to make significant progress in all three areas by continuing to deliver user-friendly, accessible technology that can support remote trials, while ensuring machine-readable output that allows for trial automation and data reuse.”

“In the next 18 months we intend to support our customers with patient recruitment and synthetic control arms, through better use of their data. We are excited to partner with Two Sigma Ventures, who bring extensive experience in leveraging the power of data and AI to disrupt incumbent industries,” Arts adds. 

Image credits: Castor

This article is produced in collaboration with StartupAmsterdam. Read more about our partnering opportunities.

close

Want to stay on top of the latest rounds, coolest tech and hottest startups?

Subscribe to our free, daily news blast and stay up-to-date!

Check your inbox or spam folder to confirm your subscription.

 - Partner content -
Nebula CTO Andre Witte
Cloud spend management 😱
Tracking cloud spend can be tricky. Learn from Nebula's CTO Andre Witte how to keep the...Show More
Tracking cloud spend can be tricky. Learn from Nebula's CTO Andre Witte how to keep the costs at bay in 2021. Show Less
Read more
Tags: featuredmedtechnews
Share7Tweet25SendShare84

Featured events

07apr10:0012:30FeaturedWorkshop: pr for startupsHow to grow your startup with the help of public relations

Partner content | Work with us

Blue Tulip Awards announce 5 finalists in the Food & Water and Education & Employment theme

Impact media foundation 5 Media offers grants up to €100,000 per year to drive a sustainable future

Here’s how cryptocurrency will take over the world

Blue Tulip Awards is driven by purpose: why innovation and equality go hand in hand

Future of coding: CTOs discuss low-code versus custom code software development for their business

Breaking news from Amsterdam | Partner

Here’s why Just Eat Takeaway is expanding its offices in Amsterdam

Amsterdam-based Veylinx uses Nobel Prize-winning approach to solve the problem of unreliable survey data; raises €1.6M

Amsterdam-based fintech unicorn Mollie enters UK market to helps merchants there grow into Europe post-Brexit

Amsterdam-based HR tech Recruitee takes a “shortcut” to a future unicorn status

  • About Silicon Canals
  • Partner with Silicon Canals
  • Contact us
  • Newsletter
  • Disclaimer
  • Privacy policy
  • Terms & Conditions Silicon Canals

Silicon Canals 2014-2020 | Website: Bright Idiots

No Result
View All Result
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdam
  • Events
  • Newsletter
  • Jobs
  • About
    • Partner with Silicon Canals
    • Team
    • Contact

Silicon Canals 2014-2020 | Website: Bright Idiots

X

This website uses cookies to ensure the best possible experience. We may share this information with our advertising and analytics partners. By clicking 'Accept', you agree to our use of cookies and similar technologies. More info